Success depends on strong support, rehabilitation, adherence, and social integration.

Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research.

“Living” drugs target specific B-cell malignancy tumor antigens, but cost hundreds of thousands of dollars. Value analysis can help determine whether to offer these customized drugs.

Rather than relying on decision aids, values-based approaches to decision making illuminate a plurality of possible right actions.

Regulations’ negative influence on patient-physician relationships can be mitigated by innovation in decision science.

Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation.

Low-resource areas are heterogeneous and changing, so establishing an evidence base for decision making about technology use is an important priority.

With properly designed programs, universities can offer transformative benefits to patients, educators, and students.

Single-procedure interventions with minimal follow-up and clear quality-of-life gain are well suited for surgical mission trips. But not all risks and benefits are easily assessed.

Louisiana has a subscription model for hepatitis C treatment, but costly medications challenge states’ capacities to cover patients.